Clinical Trial Update: CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

View source ↗

Summary

A real-world emulation study by Aetion evaluating the KEYNOTE-189 regimen in metastatic non-small cell lung cancer. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CARBOPLATIN (Carboplatin)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Aetion, Inc. | Conditions: Metastatic Nonsmall Cell Lung Cancer | Status: COMPLETED